may edition file
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
from the industry<br />
“OPHTHALMOLOGISTS ARE<br />
MOST OVERSTRETCHED IN<br />
INDIA, SO OUR AIM IS TO HELP<br />
THEM REMAIN STRAIN-FREE”<br />
With 15 million blinds, India is home for 50% of<br />
the world’s total blind population, according to<br />
a 2016 study by the World Health Organisation.<br />
While the status hasn’t changed much in the last two years,<br />
another most worrying fact is that the country is also one<br />
of the geographies in the world where the number of<br />
ophthalmologists in proportion to its total population is the<br />
lowest. And thus, it wasn’t a surprise that why the country was<br />
also infamous for the highest number of medical negligence<br />
in the area of eye care until recently. While the cases of<br />
negligence have significantly come down in the last few years,<br />
the credit to a great extent should go to the technology players<br />
who changed the scenario by bringing the much-needed<br />
sophistication into this field of care. Sandeep Bothra, Country<br />
Business Head- Surgical, Alcon Laboratories India, says that<br />
most of the recent technologies, those were introduced in<br />
the area of eye care in India, have visibly improved the way<br />
the diagnosis and procedures are done in the eye care setups<br />
and the emerging technologies will make the visualisation and<br />
diagnosis more easier and accurate, in an interview with editor<br />
CH Unnikrishnan. Edited excerpts:<br />
Eye care scenario in India has been quite challenging<br />
because of several factors including a shortage of<br />
ophthalmologists, lack of better training and infrastructure<br />
and accessibility issues with best technologies. Alcon has<br />
been in India for some time now and could you tell us what<br />
has been your experience so far and do you think the<br />
market has improved in terms of quality of care?<br />
Alcon as a global leader in eye care, we always try to<br />
discover new ways to enhance sight and improve patient lives.<br />
As we have been doing this successfully in this market through<br />
innovative products, partnerships with eye care professionals<br />
and programs that create greater access to quality eye care.<br />
We identify and develop technologies that deliver better visual<br />
outcomes and address unmet patient needs, continuously<br />
improving the options that exist today. Since our research<br />
team observes surgeries and visits clinics to gain real-world<br />
insights, we also regularly meet with<br />
eye care professionals to get their<br />
feedback on our products and their<br />
future needs. So, I can confidently say<br />
that the technology and training have<br />
significantly improved the situation in<br />
the Indian eye care. Also, the customers,<br />
as well as patients, have become quite<br />
demanding as they are already aware<br />
of the latest products and procedures.<br />
It is also evident from the change that<br />
the cases of medical negligence have<br />
come down drastically in recent time.<br />
And I am proud to say that our products<br />
touch the lives of millions of people<br />
each year living with conditions like<br />
cataracts, glaucoma, retinal diseases,<br />
and refractive errors. Since we are the<br />
only company that offers the complete<br />
line of ophthalmic surgical devices, as<br />
well as a differentiated contact lens and<br />
lens care portfolio, this also gives us a<br />
premium and most trusted position in<br />
the market.<br />
Alcon, through its social<br />
responsibility and advocacy efforts,<br />
also help to create sustainable access<br />
to eye care for patients around the<br />
world, thereby reducing the incidence<br />
of preventable blindness and visual<br />
impairment. By investing in professional<br />
education, the group help to advance<br />
the eye care industry and ultimately<br />
create better outcomes for patients and<br />
consumers.<br />
How do you see the pricing scenario<br />
here as the government is slowly<br />
58 / FUTURE MEDICINE / May 2019